Floatz logo

IBOGAINE

Brain Trauma

Johns Hopkins UniversitySmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

9 Active assets in the Brain Trauma cohort.

Asset / SponsorPhaseRating
PROPRANOLOL
Hamad Medical Corporation
Phase 4BB
Tranexamic Acid
Daniel Nishijima, MD, MAS
Phase 3BB
TESTOSTERONE UNDECYLATE
Craig Hospital
Phase 4BB
Enoxaparin
Hennepin Healthcare Research Institute
Phase 4BB
Methylphenidate
Dartmouth-Hitchcock Medical Center
Phase 4BB

View all 49 →

Same molecule, other indications

IBOGAINE is also rated in:

post-traumatic stress disorderDormant
CCC
Indicative ·
53 / 100
View asset →
cognitive disorderDormant
CCC
Indicative ·
53 / 100
View asset →
Brain InjuriesDormant
CCC
Indicative ·
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →